(MedPage Today) — Consuming high levels of the sugar substitute sucralose was linked with a worse response to immunotherapy and poorer survival in patients with melanoma and lung cancer. (Cancer Discovery)
The FDA expanded the approval of concizumab…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/116788
Author :
Publish date : 2025-08-01 17:58:00
Copyright for syndicated content belongs to the linked Source.
